SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer’s and Parkinson’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.10, 2004-10, pp. : 1369-1373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

6th International Conference on Alzheimer’s Disease and Parkinson’s Disease

By Lahiri Debomoy K

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1433-1440

Informa Healthcare

Access to resources Recommend Favorite

Tocopherol (Vitamin E) in Alzheimers Disease and Other Neurodegenerative Disorders

By Karen Berman Henry Brodaty

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

Superbugs & Superdrugs: A Focus on Antibacterials – 6th Annual SMi Conference

By Georgopapadakou Nafsika

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 191-195

Informa Healthcare

Access to resources Recommend Favorite